iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE – Get Free Report) shares saw unusually-high trading volume on Friday . Approximately 60,803 shares were traded during mid-day trading, a decline of 10% from the previous session’s volume of 67,768 shares.The stock last traded at $66.39 and had previously closed at $65.39.
iShares U.S. Pharmaceuticals ETF Price Performance
The firm has a market cap of $574.39 million, a price-to-earnings ratio of 23.46 and a beta of 0.63. The business has a 50-day moving average of $67.55 and a 200-day moving average of $68.13.
Institutional Trading of iShares U.S. Pharmaceuticals ETF
A number of large investors have recently added to or reduced their stakes in the company. Atala Financial Inc acquired a new position in shares of iShares U.S. Pharmaceuticals ETF in the fourth quarter valued at $25,000. NBC Securities Inc. acquired a new position in iShares U.S. Pharmaceuticals ETF in the 1st quarter valued at about $30,000. Arlington Trust Co LLC bought a new position in iShares U.S. Pharmaceuticals ETF in the 1st quarter valued at about $32,000. Union Bancaire Privee UBP SA acquired a new stake in iShares U.S. Pharmaceuticals ETF during the fourth quarter worth approximately $42,000. Finally, Garde Capital Inc. bought a new stake in shares of iShares U.S. Pharmaceuticals ETF during the first quarter worth approximately $46,000.
About iShares U.S. Pharmaceuticals ETF
iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.
Read More
- Five stocks we like better than iShares U.S. Pharmaceuticals ETF
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Magnificent 7 Stocks Send a Dire Warning to Markets
- How to Invest in Tech StocksĀ and Top Tech Stocks to Consider
- Why Spotify Stock Still Has Room to Run in 2025
- Most Volatile Stocks, What Investors Need to Know
- Buy the Dip: Top Tech Stocks Analysts Say Are Undervalued
Receive News & Ratings for iShares U.S. Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares U.S. Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.